Toggle Nav
Close
  • Menu
  • Setting

Anti-CD30 Antibody (Brentuximab)

Catalog No.
F2102
Anti-CD30 Antibody (Brentuximab)
Grouped product items
SizePriceStock Qty
100ug
$105.00
Ship with 3-5 days
1mg
$315.00
Ship with 3-5 days
5mg
$882.00
Ship with 3-5 days
50mg
$2,955.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Brentuximab is an antibody-drug conjugate (ADC) consisting of a monoclonal antibody and an anti-tubulin drug. Its monoclonal antibody is derived from humanized IgG1 and targets the CD30 molecule. It internalizes and releases cytotoxic drugs after binding to CD30, thereby destroying cancer cells. Brentuximab is mainly used to treat Hodgkin's lymphoma and systemic anaplastic large cell lymphoma.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.38 kDa

Shipping

Dry ice

Cas No.

2088770-90-3

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

1 mg/mL

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Brentuximab Vedotin, Adcetris

Buffer System

100 mM Pro 20 mM Arg pH 5.0.

Reactivity

Chimeric

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

CD30

Note

Please avoid freeze-thaw cycles.